POM-V Prescription Required

Bovilis Bovivac S Suspension for Injection for Cattle

Active ingredients: Salmonella dublin, Salmonella typhimurium

Form

Injection

Species

Cattle

Manufacturer

Intervet International B.V.

VMD MA No.

06376/5018

What it's used for

For the active immunisation of cattle in order to induce serological and colostral antibody production against Salmonella dublin and Salmonella typhimurium...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Salmonella dublin + Salmonel...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Bovilis Bovivac S Suspension for Injection for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For the active immunisation of cattle in order to induce serological and colostral antibody
production against Salmonella dublin and Salmonella typhimurium and in the face of an
outbreak to reduce Salmonella typhimurium
part of an overall herd management programme. This product may also contribute to
reducing S. typhimurium contamination of the environment.
Specific experimental data to quantify the duration of immunity, the effectiveness of a
single dose re-vaccination or the degree of protection from colostral antibodies has not
been generated.
Significant levels of immunity cannot be expected until two weeks after the second dose of
the primary vaccination course.

Revised: January 2025
AN: 02800/2024

None.

Cattle:
Very common
(>1 animal / 10 animals treated):
Injection site swelling
.Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Hypersensitivity reaction.
Typically, the swellings may be warm when compared with the surrounding area for up to
5 days after vaccination. Maximum size is reached within 1-6 days after vaccination.
Complete resolution or reduction to clinically insignificant reactions within 2-3 weeks after
vaccination. Swellings may be painful on palpation for 1-2 days after vaccination, which
will not require veterinary intervention.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Vaccinate healthy animals only.

Special precautions for use in animals
All stock showing overt clinical signs of salmonellosis at the time of the initial vaccination
programme should receive appropriate treatment and be fully vaccinated once they have
recovered. Any unvaccinated stock must be managed separately to vaccinated stock, with
no contact between the groups. Hygiene precautions must be instituted, where possible, to
prevent transfer of infection from one group to another.
All animals of a herd should be vaccinated.
The effect of maternally derived antibodies has not been studied, but it is likely that high
levels of maternally derived antibodies may interfere with the development of active
immunity in calves.
When vaccinating animals, stress should be avoided, particularly during pregnancy.
A small number of individuals may fail to respond to vaccination as a result of
immunological incompetence or for some other reason. In the face of an outbreak of
disease, it is therefore important to avoid vaccination of animals which have overt clinical
salmonellosis or intercurrent disease or which have a poor nutritional status. Such animals
must be isolated and treated as appropriate and then vaccinated upon clinical recovery.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Not applicable.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.

Revised: January 2025
AN: 02800/2024

No information is available on the safety and efficacy of this vaccine when used with any
other veterinary medicinal product. It is therefore recommended that no other vaccines
should be administered within 14 days before or after vaccination with this product.
A decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.

Store in a refrigerator (2 °C – 8 °C). Do not freeze. Protect from light.

Zero days.
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: inactivated bacterial vaccine.
ATCvet code: QI02AB05.

Revised: January 2025
AN: 02800/2024
To stimulate active immunity against Salmonella dublin and Salmonella typhimurium
infections.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.